Terminology Service for NFDI4Health
Exemestane/Lapatinib/Trastuzumab Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C156303
A chemotherapy regimen consisting of exemestane, lapatinib, and trastuzumab that may be used in the treatment of premenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2 (HER2; HER-2; ERBB2)-positive recurrent or metastatic breast cancer. [ ]
Term info
Label
Exemestane/Lapatinib/Trastuzumab Regimen
Synonyms
- Exemestane-Lapatinib-Trastuzumab
- Exemestane-Trastuzumab-Lapatinib
- Exemestane/Lapatinib/Herceptin
- Exemestane/Lapatinib/Trastuzumab
- Exemestane/Lapatinib/Trastuzumab Regimen
- Exemestane/Trastuzumab/Lapatinib
- Exemestane/Trastuzumab/Lapatinib Regimen
Subsets
NCIT_C160952, NCIT_C160950
NCI META CUI
CL563121
Preferred Name
Exemestane/Lapatinib/Trastuzumab Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C156303